
Afayro 40 Tablet
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Afatinib dimaleate (40mg)
Overview Afayro 40 Tablet
Afayro 40mg tablets are indicated for treating non-small cell lung cancer in adults with specific epidermal growth factor receptor (EGFR) gene mutations. Optimal absorption requires administration on an empty stomach, consistently at the same time each day. Dosage and frequency are determined by your physician based on your individual needs and may be adjusted. Strict adherence to your doctor's prescribed regimen is crucial, as incorrect usage or overdose can lead to severe adverse events. Therapeutic effects may not be apparent for weeks or months; discontinue use only as directed by your physician. Common side effects include nausea, diarrhea (which may require medical intervention), rash, and dry skin. Regular blood tests may be recommended. Photosensitivity is a potential side effect; utilize sunscreen and protective clothing when exposed to sunlight. Report any eye irritation, dryness, or redness to your doctor. Prior to commencing treatment, disclose any respiratory issues, liver or kidney impairment, or concurrent use of anti-infectives. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and breastfeeding; women of childbearing age should utilize effective contraception throughout treatment.
Primary Ingredients of Afayro 40 Tablet
No information provided. A rephrased version cannot be created.
Uses of Afayro 40 Tablet
Lung cancer (excluding small cell type)
Major Benefits of Afayro 40 Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Afayro 40 Tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
Common Side effects of Afayro 40 Tablet:
- Diarrhea
- Rash
- Dry skin
- Nausea
- Vomiting
- Loss of appetite
- Itching
- Stomatitis (Inflammation of the mouth)
- Nail disorder
How to use Afayro 40 Tablet:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Afayro 40 Tablet should be administered on an empty stomach.
How Afayro 40 Tablet works:
Afayro 40 Tablet combats cancer by targeting and blocking specific enzyme receptors—EGFR, HER2, and HER4—crucial for cancer cell proliferation. This targeted inhibition disrupts the signaling pathways that drive cancer growth, thereby curbing or slowing its progression.
SAFETY ADVICE
AlcoholSAFE
Afayro 40 Tablet may be taken with alcohol without adverse reactions.
PregnancyCONSULT YOUR DOCTOR
Using Afayro 40 Tablet during pregnancy is contraindicated due to confirmed risks to fetal development. Nevertheless, a physician might exceptionally prescribe it in critical circumstances where potential benefits outweigh the hazards. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
The use of Afayro 40 Tablet while breastfeeding is likely inadvisable. Preliminary human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Afayro 40 Tablet on driving ability is undetermined. Refrain from driving if you experience symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
Afayro 40 Tablet appears to be well-tolerated in individuals with kidney impairment. Preliminary findings indicate dose modification may be unnecessary, however, physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Afayro 40 Tablet appears to pose minimal risk for individuals with hepatic impairment. Current evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Afayro 40 Tablet :
Omit any missed Afayro 40 Tablet dose and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Afayro 40 Tablet
Label | Value |
---|---|
Chemical Type | Quinazoline-Butenamide Hybrid |
Developing Good Habits | No. |
Treatment Category | Cancer Medications |
Actions | Kinase inhibitors targeting tyrosine |